Clinical and bacteriological studies with clindamycin.
Fifty patients have been treated with clindamycin, a chemical analogue of lincomycin. Forty-four responded satisfactorily to treatment. Gastrointestinal side-effects were rare though five patients developed rashes. Most recently isolated staphylococci are clindamycin-sensitive.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001847:Bone Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006027:Glycosides / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007592:Joint Diseases / Q000188:drug therapy; D008034:Lincomycin / Q000009:adverse effects / Q000494:pharmacology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010403:Penicillin Resistance; D011759:Pyrrolidines / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines; D008034:Lincomycin